Nitta Gelatin India Q1 FY27: Strong Profit Growth Masks Margin Compression Concerns

3 hours ago
share
Share Via
Nitta Gelatin India Ltd., a speciality chemicals manufacturer focused on ossein, gelatin, and collagen peptide production, reported a consolidated net profit of ₹25.18 crores for Q1 FY27 ended June 2026, representing a robust year-on-year growth of 31.35% from ₹19.17 crores in the corresponding quarter last year. However, the quarter-on-quarter narrative was less encouraging, with profits declining 26.12% from ₹34.08 crores in Q4 FY26, raising questions about sustainability of the recent momentum.
Nitta Gelatin India Q1 FY27: Strong Profit Growth Masks Margin Compression Concerns

Following the results announcement, the stock surged 4.98% to close at ₹1,919.85 on July 31, 2026, reflecting investor optimism despite the sequential decline. With a market capitalisation of ₹1,660 crores, the micro-cap speciality chemicals player continues to command attention, having delivered exceptional returns of 102.53% over the past year and a staggering 135.85% year-to-date.

Q1 FY27 Net Profit
₹25.18 Cr
▲ 31.35% YoY
▼ 26.12% QoQ
Revenue Growth
₹140.87 Cr
▲ 1.50% YoY
▼ 12.90% QoQ
Operating Margin
24.46%
▲ 4.66pp YoY
▼ 3.61pp QoQ
Return on Equity
20.63%
Strong Capital Efficiency

The Kerala-based joint venture between Kerala State Industrial Development Corporation and Japanese giants Nitta Gelatin and Mitsubishi Corporation faces a critical juncture. While year-on-year comparisons paint an encouraging picture of growth and margin expansion, the sequential deterioration across key metrics demands closer scrutiny from investors evaluating fresh positions at current valuations.

Financial Performance: Growth Trajectory Meets Seasonal Headwinds

Nitta Gelatin India's Q1 FY27 revenue stood at ₹140.87 crores, marking a modest 1.50% increase from ₹138.79 crores in Q1 FY26. However, the 12.90% quarter-on-quarter decline from ₹161.73 crores in Q4 FY26 suggests the company experienced typical seasonal softness following a robust March quarter. The marginal year-on-year revenue growth raises concerns about demand momentum in the company's core gelatin and collagen peptide segments.

Operating profit excluding other income reached ₹34.45 crores in Q1 FY27, translating to an operating margin of 24.46%. This represents a significant 466 basis point expansion from the 19.80% margin recorded in Q1 FY26, demonstrating improved operational efficiency. Nevertheless, the sequential margin compression of 361 basis points from the 28.07% achieved in Q4 FY26 highlights the volatility inherent in the company's cost structure and pricing dynamics.

Metric Q1 FY27 Q4 FY26 Q3 FY26 Q2 FY26 Q1 FY26
Revenue (₹ Cr) 140.87 161.73 149.72 138.07 138.79
QoQ Change (%) -12.90% +8.02% +8.44% -0.52%
Net Profit (₹ Cr) 25.18 34.08 25.57 18.43 19.17
QoQ Change (%) -26.12% +33.28% +38.74% -3.86%
Operating Margin (%) 24.46% 28.07% 25.29% 18.64% 19.80%
PAT Margin (%) 17.95% 21.08% 17.11% 13.68% 14.16%

The profit after tax margin contracted to 17.95% in Q1 FY27 from 21.08% in the previous quarter, though it remained substantially ahead of the 14.16% recorded in Q1 FY26. Employee costs rose to ₹13.59 crores from ₹12.64 crores sequentially, whilst depreciation remained relatively stable at ₹4.01 crores. The company's tax rate of 25.60% in Q1 FY27 was marginally lower than the 26.42% in Q4 FY26, providing modest support to bottom-line performance.

Other income contributed ₹3.67 crores in Q1 FY27, down from ₹4.86 crores in the previous quarter, reflecting lower treasury income or non-operating gains. Interest expenses remained negligible at ₹0.14 crores, underscoring the company's virtually debt-free status and strong balance sheet position.

Operational Excellence: Strong Returns Underpinned by Capital Efficiency

Nitta Gelatin India's return on equity (ROE) averaged 20.63% over recent periods, demonstrating the company's ability to generate attractive returns on shareholder capital. This metric places the company in a favourable position within the speciality chemicals sector, where capital-intensive operations often struggle to achieve double-digit ROEs. The latest ROE of 19.17% remains robust, indicating consistent capital efficiency despite the quarterly profit volatility.

Even more impressive is the company's return on capital employed (ROCE), which averaged 29.74% and reached 36.84% in the most recent period. Higher ROCE values indicate superior capital efficiency and profitability, and Nitta Gelatin's performance on this metric stands as a key strength. The company's ability to deploy capital at such attractive returns suggests a sustainable competitive advantage in its niche gelatin and collagen peptide markets.

Balance Sheet Strength: Net Cash Position Provides Strategic Flexibility

Nitta Gelatin India operates with virtually zero long-term debt, having reduced its borrowings from ₹4.22 crores in March 2025 to nil by March 2026. The company's net debt-to-equity ratio of -0.35 indicates it holds more cash than debt, classifying it as a net cash company. With shareholder funds of ₹511.25 crores as of March 2026 and minimal leverage, the company possesses significant financial flexibility for growth investments or shareholder returns. Current assets of ₹388.86 crores comfortably exceed current liabilities of ₹63.21 crores, ensuring strong liquidity and working capital management.

The company's five-year sales growth of 8.22% appears modest, but EBIT growth of 33.25% over the same period demonstrates significant operating leverage and margin expansion. This divergence suggests Nitta Gelatin has successfully improved its product mix, enhanced operational efficiency, or benefited from favourable raw material dynamics. The average EBIT-to-interest coverage of 58.26 times provides an enormous cushion, though this metric loses some relevance given the company's minimal debt burden.

✓ Key Operational Strengths:

Nitta Gelatin India's operational profile exhibits several compelling attributes: virtually debt-free balance sheet, strong double-digit ROE and ROCE metrics exceeding 20% and 29% respectively, consistent profitability with improving margins over the medium term, and zero promoter pledging indicating management confidence. The company's position as a joint venture with established Japanese partners Nitta Gelatin and Mitsubishi Corporation provides access to technical expertise and potentially stable raw material sourcing arrangements.

Industry Dynamics: Niche Positioning in Speciality Chemicals

Nitta Gelatin India operates in the specialised segments of ossein, gelatin, and collagen peptide manufacturing—niche markets with specific applications in pharmaceuticals, food processing, nutraceuticals, and cosmetics. The company's products serve as critical inputs for capsule manufacturing, confectionery, dairy products, and increasingly popular collagen-based health supplements. This positioning provides some insulation from broader commodity chemical cycles, though the company remains exposed to raw material price volatility and demand fluctuations in end-user industries.

The speciality chemicals sector has experienced mixed performance, with the industry delivering an 11.33% return over the past year—substantially below Nitta Gelatin's exceptional 102.53% performance. This significant outperformance of 91.20 percentage points suggests the company has benefited from company-specific factors beyond sectoral tailwinds, including improved operational execution, margin expansion initiatives, or investor recognition of its quality credentials.

Gelatin demand globally has witnessed steady growth driven by pharmaceutical applications, particularly capsule manufacturing for generic drugs and supplements. The collagen peptide segment has emerged as a high-growth opportunity, with increasing consumer awareness about joint health, skin care, and sports nutrition driving demand. Nitta Gelatin's exposure to these growing segments positions it favourably, though competition from international players and potential raw material constraints warrant monitoring.

Company Market Cap (₹ Cr) P/E (TTM) P/BV ROE (%) Div Yield (%)
Nitta Gelatin 1,660 17.68 3.39 20.63 0.37
Jubilant Agri 21.09 5.98 28.36
NOCIL 46.21 1.55 7.76 0.91
Camlin Fine NA (Loss Making) 2.36 4.73
S H Kelkar & Co. 48.56 1.66 9.04 1.22
Titan Biotech 58.20 9.58 19.48 0.10

Peer Comparison: Attractive Valuation Relative to Quality

Nitta Gelatin India's price-to-earnings ratio of 17.68 times trailing twelve-month earnings appears remarkably attractive when compared to the broader speciality chemicals peer group average of approximately 44 times. The company trades at a substantial discount to peers like NOCIL (46.21x), S H Kelkar & Co. (48.56x), and Titan Biotech (58.20x), despite delivering a superior ROE of 20.63% compared to most peers.

The company's price-to-book value of 3.39 times sits in the middle range of the peer group, higher than NOCIL (1.55x) and S H Kelkar (1.66x) but significantly lower than Jubilant Agri (5.98x) and Titan Biotech (9.58x). Given Nitta Gelatin's ROE of 20.63%—substantially higher than NOCIL's 7.76% or S H Kelkar's 9.04%—the modest premium to book value appears justified and potentially attractive.

The dividend yield of 0.37% lags behind peers like S H Kelkar (1.22%) and NOCIL (0.91%), reflecting a conservative payout ratio of just 8.65%. This low payout suggests management prioritises capital retention for growth investments or balance sheet strengthening, though it offers limited income appeal for dividend-focused investors. The company declared a dividend of ₹6.99 per share with an ex-dividend date of July 24, 2026.

"At 17.68 times earnings with an ROE exceeding 20%, Nitta Gelatin trades at a compelling discount to speciality chemical peers, despite demonstrating superior capital efficiency and a fortress balance sheet."

Valuation Analysis: Attractive Entry Point Despite Recent Run-Up

Despite the stock's remarkable 102.53% surge over the past year and 135.85% year-to-date gain, Nitta Gelatin India's valuation metrics suggest the rally has been driven more by earnings growth and multiple re-rating from depressed levels rather than speculative excess. The current P/E ratio of 17.68 times remains below the industry average of 44 times, whilst the company's quality metrics—particularly its 20.63% ROE and 29.74% ROCE—justify a premium valuation.

The enterprise value-to-EBITDA multiple of 11.37 times and EV-to-EBIT of 12.77 times appear reasonable for a company demonstrating consistent profitability, strong returns on capital, and a net cash balance sheet. The PEG ratio of 0.63 (calculated using five-year EBIT growth of 33.25%) suggests the stock remains attractively valued relative to its growth profile, with any PEG ratio below 1.0 typically indicating potential undervaluation.

P/E Ratio (TTM)
17.68x
vs Industry 44x
Price to Book
3.39x
Justified by 20.6% ROE
EV/EBITDA
11.37x
Reasonable for Quality
PEG Ratio
0.63
Below 1.0 threshold

The proprietary Mojo Score of 64 out of 100 places the stock in "HOLD" territory, with the overall valuation grade marked as "ATTRACTIVE" as of August 2026. Notably, the valuation grade has oscillated between "Attractive" and "Fair" over recent months, suggesting the stock trades near fair value with periodic opportunities emerging during temporary weakness. The current price of ₹1,919.85 sits approximately 8.05% below the 52-week high of ₹2,088.00, whilst remaining 150.94% above the 52-week low of ₹765.05.

Shareholding Pattern: Stable Promoter Base with Minimal Institutional Interest

Nitta Gelatin India's shareholding structure reflects its joint venture heritage, with promoter holding remaining rock-steady at 74.48% across the past five quarters through June 2026. The promoter group comprises Nitta Gelatin Inc. holding 42.96% and Kerala State Industrial Development Corporation controlling 31.53%, providing strategic and operational stability. The absence of any promoter pledging underscores management's confidence and financial strength.

Category Jun'26 Mar'26 Dec'25 QoQ Change
Promoter 74.48% 74.48% 74.48% 0.00%
FII 0.05% 0.00% 0.00% +0.05%
Mutual Funds 0.01% 0.01% 0.01% 0.00%
Other DII 0.94% 0.91% 0.73% +0.03%
Non-Institutional 24.52% 24.59% 24.77% -0.07%

Institutional participation remains minimal, with just 1.00% combined holdings from mutual funds, insurance companies, and other domestic institutional investors. Foreign institutional investor (FII) holding increased marginally to 0.05% in June 2026 from nil in previous quarters, representing nascent international interest. The low institutional ownership of approximately 1% suggests the stock remains largely undiscovered by mainstream funds, potentially offering upside as awareness builds.

The gradual increase in Other DII holdings from 0.34% in June 2025 to 0.94% in June 2026 indicates growing domestic institutional recognition, though the absolute levels remain modest. Non-institutional holdings (retail and high-net-worth individuals) account for 24.52% of equity, declining marginally from 25.16% a year ago. The shareholding pattern suggests significant room for institutional accumulation should the company's performance trajectory continue.

Stock Performance: Exceptional Returns Driven by Fundamental Re-rating

Nitta Gelatin India has delivered extraordinary returns across all time horizons, dramatically outperforming both the broader market and its speciality chemicals peer group. The stock's one-year return of 102.53% compares favourably against the Sensex decline of 3.81%, generating alpha of 106.34 percentage points. Year-to-date performance of 135.85% versus the Sensex fall of 8.36% translates to alpha of 144.21 percentage points, underscoring the stock's exceptional momentum.

Period Stock Return Sensex Return Alpha
1 Week +0.51% +2.68% -2.17%
1 Month +11.46% +1.52% +9.94%
3 Month +96.06% +1.54% +94.52%
6 Month +127.03% -5.07% +132.10%
Year-to-Date +135.85% -8.36% +144.21%
1 Year +102.53% -3.81% +106.34%
3 Years +143.07% +17.39% +125.68%
5 Years +554.57% +48.51% +506.06%

The three-month surge of 96.06% and six-month gain of 127.03% reflect an acceleration in the stock's re-rating, likely driven by improving quarterly results, margin expansion, and growing investor recognition of the company's quality attributes. The stock trades above all key moving averages—5-day (₹1,870.50), 20-day (₹1,882.99), 50-day (₹1,712.20), 100-day (₹1,328.82), and 200-day (₹1,077.90)—indicating strong technical momentum.

The stock's beta of 1.50 classifies it as a high-beta security, exhibiting greater volatility than the broader market. With annualised volatility of 44.17% over the past year compared to the Sensex's 13.58%, Nitta Gelatin presents a high-risk, high-return proposition. The risk-adjusted return of 2.32 over one year suggests investors have been adequately compensated for the elevated volatility, though future returns may moderate as the stock approaches fair value.

Investment Thesis: Quality Micro-Cap at Reasonable Valuation

Nitta Gelatin India's investment case rests on several compelling pillars: a niche market position in gelatin and collagen peptides with applications across pharmaceuticals, nutraceuticals, and food processing; exceptional capital efficiency demonstrated by 20.63% ROE and 29.74% ROCE; a fortress balance sheet with net cash position and zero long-term debt; consistent profitability with improving margins over the medium term; and reasonable valuation at 17.68 times earnings despite recent price appreciation.

Valuation Grade
ATTRACTIVE
Quality Grade
AVERAGE
Financial Trend
POSITIVE
Technical Trend
BULLISH

The company's quality grade of "AVERAGE" reflects its solid but not exceptional long-term financial performance, with five-year sales growth of 8.22% appearing modest. However, the 33.25% EBIT growth over the same period demonstrates significant operating leverage and margin expansion capability. The positive financial trend in recent quarters, evidenced by 63.76% growth in half-yearly PAT, supports a constructive near-term outlook.

Technical indicators remain uniformly bullish across weekly and monthly timeframes, with MACD, Bollinger Bands, KST, and Dow Theory all signalling positive momentum. The stock's position above all major moving averages provides technical support, though the 96.06% three-month surge raises concerns about near-term consolidation or profit-taking.

Key Strengths & Risk Factors

✓ KEY STRENGTHS

  • Exceptional Capital Efficiency: ROE of 20.63% and ROCE of 29.74% demonstrate superior capital deployment and profitability compared to peers
  • Fortress Balance Sheet: Net cash position with zero long-term debt provides financial flexibility for growth investments or shareholder returns
  • Attractive Valuation: Trading at 17.68x earnings versus industry average of 44x, with PEG ratio of 0.63 suggesting undervaluation relative to growth
  • Strong Margin Expansion: Operating margins improved from 19.80% to 24.46% year-on-year, demonstrating pricing power and operational efficiency
  • Stable Promoter Base: 74.48% promoter holding with zero pledging, backed by reputable Japanese partners Nitta Gelatin and Mitsubishi Corporation
  • Niche Market Position: Specialised focus on gelatin and collagen peptides provides insulation from commodity chemical cycles
  • Consistent Profitability: Demonstrated ability to maintain profitability across economic cycles with improving earnings trajectory

⚠ KEY CONCERNS

  • Sequential Profit Decline: 26.12% QoQ drop in net profit raises questions about earnings sustainability and seasonal volatility
  • Modest Revenue Growth: Just 1.50% YoY revenue growth in Q1 FY27 suggests limited demand momentum in core markets
  • Margin Volatility: Operating margin contracted 361 basis points QoQ, highlighting vulnerability to input cost fluctuations
  • Minimal Institutional Ownership: Just 1% institutional holding creates liquidity concerns and limits discovery by mainstream investors
  • High Volatility: Beta of 1.50 and annualised volatility of 44.17% make the stock unsuitable for risk-averse investors
  • Micro-Cap Liquidity: Market cap of ₹1,660 crores limits institutional participation and creates execution challenges for large positions
  • Recent Price Run-Up: 102.53% one-year gain and 135.85% YTD surge raise concerns about near-term consolidation or profit-taking

Outlook: What to Watch in Coming Quarters

✓ POSITIVE CATALYSTS

  • Sustained revenue growth above 10% YoY demonstrating demand recovery
  • Operating margin stabilisation above 25% indicating pricing power
  • Increased institutional participation driving liquidity and valuation re-rating
  • Capacity expansion announcements leveraging strong balance sheet
  • Consistent quarterly profit growth reducing seasonal volatility concerns

⚠ RED FLAGS

  • Further sequential profit declines suggesting structural demand weakness
  • Operating margin compression below 20% indicating pricing pressure
  • Revenue growth remaining below 5% YoY for consecutive quarters
  • Promoter stake reduction or any pledging activity
  • Deteriorating working capital metrics or cash flow generation

The coming quarters will prove critical in determining whether Nitta Gelatin India can sustain its impressive margin expansion and profit growth trajectory. Investors should monitor revenue growth trends closely, as the modest 1.50% YoY increase in Q1 FY27 raises questions about demand momentum. The company's ability to maintain operating margins above 24-25% despite raw material volatility will signal pricing power and operational efficiency.

Institutional participation remains a key monitoring point, with the current 1% holding suggesting significant room for accumulation should performance remain robust. Any meaningful increase in mutual fund or FII holdings could provide additional valuation support and improve liquidity. The company's capital allocation decisions—whether deploying its net cash position for organic expansion, acquisitions, or enhanced shareholder returns—will shape the medium-term investment case.

The Verdict: Quality Micro-Cap Worth Holding, Caution on Fresh Entry

HOLD

Score: 64/100

For Fresh Investors: Exercise caution given the 102.53% one-year price surge and 135.85% YTD gain. Whilst the stock trades at attractive valuations relative to quality metrics (17.68x P/E with 20.63% ROE), the recent run-up suggests limited margin of safety. Consider accumulating on dips towards ₹1,600-1,700 levels or await Q2 FY27 results for revenue growth confirmation. The sequential profit decline and modest revenue growth warrant monitoring before committing fresh capital.

For Existing Holders: Continue holding positions accumulated at lower levels. The company's fortress balance sheet, strong ROE/ROCE metrics, and reasonable valuation provide downside protection. The 26.12% QoQ profit decline appears seasonal rather than structural, and year-on-year comparisons remain encouraging. Maintain positions with a medium-term perspective, monitoring quarterly revenue trends and margin sustainability. Consider partial profit-booking if the stock approaches ₹2,200-2,300 levels without corresponding earnings growth.

Fair Value Estimate: ₹2,100 (9.38% upside from current levels), based on 20x trailing earnings—a modest premium to current 17.68x justified by superior ROE, net cash position, and growth potential. However, execution on revenue growth and margin sustainability will determine whether this target proves achievable over the next 12-18 months.

Note- ROCE= (EBIT - Other income)/(Capital Employed - Cash - Current Investments)

⚠️ Investment Disclaimer

This article is for educational and informational purposes only and should not be construed as financial advice. Investors should conduct their own due diligence, consider their risk tolerance and investment objectives, and consult with a qualified financial advisor before making any investment decisions. Past performance does not guarantee future results. The stock market involves risk, and investors may lose principal. The views expressed are based on publicly available information as of August 01, 2026, and are subject to change without notice.

{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News